Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure
Harnessing the ability of the immune system to eradicate cancer has been a long-held goal of oncology. Work from the last two decades has finally brought immunotherapy into the forefront for cancer treatment, with demonstrable clinical success for aggressive tumors where other therapies had failed....
Main Authors: | Katie L. Anderson, Jaime F. Modiano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-10-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2306-7381/2/4/363 |
Similar Items
-
Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway
by: Konkankit Veerauo V, et al.
Published: (2011-11-01) -
Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
by: Donald Bastin, et al.
Published: (2016-08-01) -
Oncolytic viruses as immunotherapy: progress and remaining challenges
by: Aurelian L
Published: (2016-05-01) -
Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient
by: Lidia Franco-Luzón, et al.
Published: (2020-04-01) -
Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients
by: Agnès Hamzaoui, et al.
Published: (2003-01-01)